Pharmafile Logo
Pharmafocus logo
Advanced Search

OSI

Showing 3 posts of 3 posts found.

OSI Pharmaceuticals

Astellas set to acquire OSI Pharmaceuticals for $4bn

May 17, 2010
Research and Development, Sales and Marketing Astellas, M&A, MA, OSI

After four months and several failed bids Astellas Pharma has signed a definitive merger agreement with US biotech firm OSI …

News
OSI Pharmaceuticals

OSI resists Astellas and invites other offers

March 16, 2010
Sales and Marketing Astellas, OSI, merger

A new takeover bid launched by Japanese pharma company Astellas for OSI Pharma has been rejected by the company’s board. …

News
OSI Pharmaceuticals

Astellas moves in on OSI Pharmaceuticals

March 2, 2010
Sales and Marketing Astellas, Astellas Pharma Europe, OSI

Astellas has launched a hostile takeover bid for OSI Pharmaceuticals, going directly to stockholders with a proposal that values the US …

News

Latest content

Eisai and Biogen’s Leqembi launched for Alzheimer’s treatment in China

June 28, 2024

AbbVie’s Tepkinly gains positive CHMP opinion for follicular lymphoma treatment

June 28, 2024

IDEAYA Biosciences announces first-patient-in for phase 1 clinical trial evaluating IDE397 and Trodelvy combination in MTAP-deletion bladder cancer

June 27, 2024

Immunotherapy created at Roswell Park Comprehensive Cancer Center given expanded ODD by FDA

June 27, 2024

Abcuro completes enrolment for phase 2/3 IBM treatment trial

June 26, 2024